UK Tobacco Wholesalers Excited About TAAT ™ After First Commercial Shipment Arrives


Image 1

The Company has produced compliant packaging designs for TAAT ™ in the UK, where one of its competitive advantages is its exemption from the “plain packaging” laws that apply to tobacco products. The illustration above is the complete package design for TAAT ™ “Original”, which may be sold at a lower price than major tobacco cigarettes in the UK.

The Company has produced compliant packaging designs for TAAT ™ in the UK, where one of its competitive advantages is its exemption from the “plain packaging” laws that apply to tobacco products. The illustration above is the complete package design for TAAT ™ “Original”, which may be sold at a lower price than major tobacco cigarettes in the UK.

LAS VEGAS and VANCOUVER, British Columbia, October 22, 2021 (GLOBE NEWSWIRE) – TAAT â„¢ GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT™”) is pleased to announce that several large scale tobacco wholesalers in the UK have received TAAT â„¢ and have expressed a high level of enthusiasm for the product due to its many advantages over traditional tobacco cigarettes. In a dated press release September 29, 2021, the company announced that more than 43,000 packs of TAAT â„¢ have arrived in London under more than CAD $ 1,200,000 in UK and Ireland purchase orders issued by Green Global Earth (“GGE “). In less than a calendar year, the Company has placed TAAT â„¢ in approximately 1,200 retail stores across the United States through strategies it intends to employ as part of its first international launches of TAAT â„¢ in markets including UK.

As a non-tobacco product, TAAT â„¢ enjoys freedoms that are not granted to products containing tobacco or nicotine. Tobacco wholesalers in the UK who received TAAT â„¢ throughout October 2021 noted that in-store promotional graphics may be displayed for TAAT â„¢ in order to cultivate interest in the product among legal age smokers. , while such advertisements would not be permitted for tobacco cigarette brands. In addition, being exempt from certain taxes on tobacco and nicotine products, TAAT â„¢ may be sold at a lower price in the UK compared to major brands of tobacco cigarettes; a particularly important consideration in the United Kingdom where the average price of a pack of tobacco cigarettes is about double the average price in the United States (described in the April 30, 2021 Press release). Additionally, UK tobacco product packaging laws require tobacco cigarettes to be sold in uniform packaging with negligible brand identifiers such as colors and logos; although the Company’s UK distribution partners have confirmed that TAAT â„¢ packs can be sold in a format substantially similar to the standard design currently used in the United States (bearing the respective colors of each TAAT â„¢ variety).

A photo accompanying this announcement is available at

Readers using news aggregation services may not be able to view the above media. Please access SEDAR or Investor Relations section of the Company’s website for a version of this press release containing all published media.

Based on the results of the Company’s existing dialogues with UK tobacco wholesalers, TAAT â„¢ intends to ship a full container shipment to the UK during the fourth quarter of 2021, from which TAAT â„¢ would be placed in retail outlets to include supermarkets and convenience stores. stores. As part of these dialogues, the company is also forming a collection of in-store promotional graphics to include window decals, which may allow UK TAAT â„¢ retailers to capitalize on their ability to promote the product to their major smoking customers.

TAAT â„¢ CEO Setti Coscarella commented, “It is very exciting for us to be in these stages of executing TAAT ™’s first international expansion. We have discussed at length how we can compete in the UK based on price, package design and the merits of the product itself. One thing we haven’t gone into detail on, however, is that it appears to be much easier to launch nationally in the UK, in the absence of the complexity of state and territory laws. like those commonly found in the United States. We look forward to finalizing our first international store placements with UK tobacco wholesalers as part of our next steps to grow the tobacco industry‘s market share globally. “

On behalf of the Board of Directors of the Company,


“Setti Coscarella”

Setti Coscarella, CEO and Director

For more information, please contact:

TAAT â„¢ Investor Relations
1-833-TAAT-United States (1-833-822-8872)
[email protected]


About TAATâ„¢ Global Alternatives Inc.

The Company has developed TAAT â„¢, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in the “Original”, “Smooth” and “Menthol” varieties. The base material of TAAT â„¢ is Beyond Tobacco â„¢, a proprietary blend that undergoes a patent pending refinement technique that makes its scent and taste resemble tobacco. Under the leadership of management with the “Big Tobacco” pedigree, TAAT â„¢ was first launched in the United States in the fourth quarter of 2020 as the company seeks to position itself in the $ 814 billion mark.1 the global tobacco industry.

For more information, please visit

The references

1 British American Tobacco – The Global Market

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “believes” , “Intention”, “” anticipates “or” does not anticipate “, or” believes “, or variations of these words and expressions or states that certain actions, events or results” could “,” could “,” would “,” could “or” would “be taken, occur or be attained. Forward-looking information contained in this press release includes statements regarding the anticipated performance of TAAT â„¢ in the tobacco industry, in addition to the following : Potential results of the Company’s dialogues with tobacco wholesalers and the completion of the Company’s first container shipment of TAAT â„¢ to the UK Forward-looking information reflects management’s current expectations based on information currently being told available and are subject to a number of risks and uncertainties which may cause the results to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in the preparation of forward-looking information are reasonable, such information should not be relied on unduly and no guarantee can be given that such events will occur within the time limits disclosed or in the future. all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes in the growth and size of tobacco markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly changing environment. New risk factors emerge from time to time, and it is impossible for the management of the Company to predict all risk factors, nor can the Company assess the impact of all factors on the business of the Company. Company or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. , unless required by applicable law.

The statements contained in this press release have not been evaluated by Health Canada or the United States Food and Drug Administration. Because everyone is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claim or guarantee can be made as to the effects of the Company’s products on the health and well-being of an individual. The Company’s products are not intended to diagnose, treat, cure or prevent any disease.

This press release may contain brand names of third party entities (or their respective offerings with brand names) generally in reference to (i) the relationship between the Company and third party entities mentioned in this release and / or (ii ) the client / supplier / service provider parties whose relationship with the Company is / are mentioned in this press release. All rights to these trademarks are reserved by their respective owners or licensees.

Statement Regarding Third Party Investor Relations Firms

Information relating to investor relations firms retained by TAAT â„¢ Global Alternatives Inc. can be viewed under the Company’s profile on


Comments are closed.